SCHEMBL11272186

SCHEMBL11272186

CCOC(=O)C(=CN(CC(=O)[O-])c1ccccc1)C(=O)OCC.[Na+]

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.50
KMT2A Q03164 7/20 0.50
MAPT P10636 7/20 0.44
GAA P10253 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
DHODH Q02127 2/20 0.42
TSHR P16473 1/20 0.41
LMNA P02545 4/20 0.41
PLIN1 O60240 1/20 0.41
POLB P06746 1/20 0.41
PLIN5 Q00G26 1/20 0.41
ABHD5 Q8WTS1 1/20 0.41
CYP1A2 P05177 4/20 0.40
CYP2C19 P33261 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HSP90AA1 P07900 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11281728 0.84 MEN1 (0.50) MEN1KMT2AMAPTGAATDP1
SCHEMBL5094475 0.78 MEN1 (0.60) MEN1KMT2AMAPTGAATDP1
SCHEMBL11848042 0.77 ALDH1A1 (0.41) MEN1KMT2AGAATSHRPOLB
SCHEMBL5089790 0.77 MEN1 (0.58) MEN1KMT2AMAPTGAATDP1
SCHEMBL10862444 0.74 ALDH1A1 (0.50) MEN1KMT2AMAPTGAATDP1
SCHEMBL5768033 0.74 MEN1 (0.55) MEN1KMT2AMAPTGAATDP1
Lithium Ion SCHEMBL11854850 0.74 ALDH1A1 (0.41) MEN1KMT2AGAATSHRPOLB
SCHEMBL398239 0.73 MEN1 (0.54) MEN1KMT2AMAPTGAATDP1
SCHEMBL11688818 0.71 MEN1 (0.47) MEN1KMT2AMAPTGAATDP1
SCHEMBL9094971 0.70 MEN1 (0.54) MEN1KMT2AMAPTGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4352800-A ANTIBIOTICS, BLOOD KYOTO YAKUHIN KYOGO KABUSHIKI KAISHA (JP) 1982-10-05 US disclosed
US-4277465-A ENAMINE DERIVATIVE KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) 1981-07-07 US disclosed
EP-0009609-A2 Adjuvant for promoting absorption of therapeutically active substances through the digestive tract, pharmaceutical composition comprising said adjuvant and process for preparing said pharmaceutical composition; enamine derivatives KYOTO YAKUHIN KOGYO KABUSHIKI KAISHA (JP) 1980-04-16 EP disclosed